Randy Schekman, a co-recipient of the 2013 Nobel Prize in Physiology or Medicine, participated in an “Ask Me Anything” (AMA) session on Reddit this weekend. Schekman, a Cell Biologist at the University of California, Berkeley, was jointly awarded a Nobel Prize for his work in understanding the transport mechanisms involved in the export of proteins from cells. Last week, he authored an editorial in the Guardian that accused the practices of journals like Cell, Nature, and Science of distorting science and has been the subject of both criticism and praise in the scholarly publishing world.
In his editorial, Schekman specifically calls out Cell, Nature, and Science (C/N/S) who are among the most prestigious journals in the biological and medical sciences.
“These journals aggressively curate their brands, in ways more conducive to selling subscriptions than to stimulating the most important research. Like fashion designers who create limited-edition handbags or suits, they know scarcity stokes demand, so they artificially restrict the number of papers they accept.” [Source]
From the Reddit AMA, the focus of Schekman’s criticism of C/N/S is the artificial restriction of publishing only the papers that fit in the print run of these journals. “Why should we have such a limitation in the 21st century?” he asks. Schekman marks this practice as a distinguishing characteristic of a “luxury” journal as well as the use of a professional editorial staff rather than working scientists in the field. This combination of management priorities, Schekman argues, distorts scientific discourse by emphasizing fashionable topics at the expense of good science.
Schekman is a supporter of the open access movement and is the Editor-in-Chief of eLife, an open access journal of life sciences papers. His boycott of C/N/S has drawn criticism for his eLife affiliation and his previous 46 publications in these journals. [Read the AMA here]